Manufacturer:

Mylan

Name:

OGIVRI

Category:

Q Code

HCPCS:

Q5114

NDC(s):

67457-0847-44, 67457-0991-15,

Primary Type:

Biosimilar

Route of Administration:

Intravenous

About:

OGIVRI is a Biosimilar drug manufactured by Mylan and administered via the Intravenous route of administration. The Q Code: Q5114 is aligned to the drug OGIVRI.